One signaling pathway that is defective in a large proportion of cancer cells (∼70–75%) is the interferon (IFN) pathway, which mediates the first line of cellular anti-viral response [3], [4], [5], [6], [7]. This evidence concerns the gene IFNA1 and cancer.